New diabetes clinical trial: Tolerance to Islet Allotransplants in Diabetes
Published on: December 06, 2023 at 11:00PM
Conditions: Diabetes Mellitus Type 2 - Insulin-Treated
Interventions: Biological: ToleraCell-001; Biological: ToleraCell-002; Drug: DFI-105; Drug: Etanercept; Drug: Tocilizumab; Drug: Sirolimus
Sponsors: Diabetes Free, Inc.
Not yet recruiting
https://ift.tt/q5rXsc2
Conditions: Diabetes Mellitus Type 2 - Insulin-Treated
Interventions: Biological: ToleraCell-001; Biological: ToleraCell-002; Drug: DFI-105; Drug: Etanercept; Drug: Tocilizumab; Drug: Sirolimus
Sponsors: Diabetes Free, Inc.
Not yet recruiting
https://ift.tt/q5rXsc2
Comments
Post a Comment